Fysisk aktivitet som supplerende behandling til opioidsubstitutionsterapi
In terms of research, it is documented that exercise has a positive effect on mental disorders. Studies have shown positive correlations between physical and mental health, also among substance users. Such a study has never been performed on patients in opioid substitution therapy (OST). Documentation on the physical health of patients and the effect of exercise is very limited. Treatment of substance users is a research area with insufficient knowledge about certain treatment effects. It is important that a treatment can both support and promote the user's own resources and efforts to change their habits of substance use.
The objective of this project is to examine the effect of exercise for OST patients, measured in relation to cognitive function and physical form. The target group consists of OST patients from 18 years of age and up, of both sexes, and on stable medication. At least 60 participants should complete the project, which is designed as a controlled randomized study (RCT). Participants in the intervention group start to exercise immediately after baseline testing. Participants in the control group are on a waiting list and will start to exercise after twelve weeks. Both groups undergo testing at baseline, after three, six and 12 months. Testing consists of two parts: A battery of cognitive and psychosocial assessments and an assessment of physical variables.
The research questions of this project are important in a public health perspective. Generated knowledge can be quickly applied to local treatment institutions in Norway.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Bergen, Norge
- Haukeland University Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Participants must sign a informed consent form
- Must be participating in an opioid substitution program
- Must be on a steady fixed dose of medication
- Must be at least 18 years of age
Exclusion Criteria:
- Pregnancy
- Being in opioid substitution program for less than three months
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Intervention
Exercise intervention |
Exercise of choice with a training contact: 3 hrs/week, total of 12 weeks. |
|
Aktiv komparator: Control
The control group is a waiting list group. The participants will receive exercise intervention after twelve weeks of treatment as usual. |
Exercise of choice with a training contact: 3 hrs/week, total of 12 weeks. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Height and weight
Tidsramme: 12 weeks
|
Weight and height will be combined to report BMI in kg/m^2 |
12 weeks
|
|
Endurance
Tidsramme: 12 weeks
|
Ventilatory threshold/VO2max (endurance test on treadmill) |
12 weeks
|
|
Strength
Tidsramme: 12 weeks
|
Push-ups (maximal test where the participants perform a maximum number of correct push-ups) |
12 weeks
|
|
Balance
Tidsramme: 12 weeks
|
Stork Balance Test (timed test where the goal is to keep one's balance as long as possible) |
12 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Alcohol use
Tidsramme: 12 weeks
|
AUDIT-E |
12 weeks
|
|
Drug use
Tidsramme: 12 weeks
|
DUDIT-E |
12 weeks
|
|
Executive functions
Tidsramme: 12 weeks
|
Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) |
12 weeks
|
|
Satisfaction with life
Tidsramme: 12 weeks
|
Satisfaction With Life Scale (SWLS) Values/scores:
Results (sum of scores/values): 31 - 35 Extremely satisfied 26 - 30 Satisfied 21 - 25 Slightly satisfied 20 Neutral 15 - 19 Slightly dissatisfied 10 - 14 Dissatisfied 5 - 9 Extremely dissatisfied The higher the score the better the outcome. |
12 weeks
|
|
Sleep quality
Tidsramme: 12 weeks
|
Pittsburgh Sleep Quality Index (PSQI) |
12 weeks
|
|
Attention
Tidsramme: 12 weeks
|
Connors Continuous Performance Test (CPT 3) |
12 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Studieleder: Asgeir Mamen, PhD, Kristiania University College
- Studieleder: Lars Thore Fadnes, PhD, University of Bergen
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2013/00731
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .